It says so right on the label that they are to be used as an adjunct to a nutrition and exercise program
The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 9.7% during the forecast period, till 2035
Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults
The B12 Injection delivers methylcobalamin for energy, neurological function, and red blood cell production
AOD-9604 is administered via subcutaneous injection into fatty tissue, with the abdominal region being the preferred site